logo-loader
Callitas Health Inc.

Callitas Health signs product development agreement with condom supplier LifeStyles

The company will develop sexual-wellness products for LifeStyles, with the first item launching in March

Beakers of fluid
Consumer healthcare is a focus for Cincinnati-based Callitas

Callitas Health Inc (CSE:LILY) (OTCMKTS:WKULF) said Wednesday that it has signed a product development and manufacturing agreement with LifeStyles, the condom company.

Cincinnati-based Callitas will develop sexual-wellness products for LifeStyles, with the first item launching in March. The companies signed a letter of intent in August to develop and supply finished goods for retail sale.

READ: Callitas Health strikes up new partnership with NuEthix

“We’ve been impressed with LifeStyles and its model of business,” Callitas CEO James M. Thompson said in a statement. “Callitas looks forward to our ongoing relationship, one that will be mutually beneficial for both companies’ futures.”

Formed in 2015, Callitas focuses on clinical-stage pharmaceutical development, consumer healthcare and cannabis delivery devices. The company’s ToConceive fertility-enhancing moisturizer is designed to aid in conception.

'Joyful moments'

LifeStyles CEO Jeyan Heper added that the agreement is part of the company’s mission "to spark billions of joyful moments every day.”

Shares of Callitas slipped C$0.01 to C$0.11 in Tuesday’s Canadian trading.

Last week, the company announced that it had signed a letter of intent with NuEthix LLC to manufacture and supply CannaStrip products for retail sale in the US.

Contact Dennis Fitzgerald at [email protected]

Quick facts: Callitas Health Inc.

Price: $0.11

Market: CSE
Market Cap: $3.62 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Callitas Health Inc. named herein, including the promotion by the Company of Callitas Health Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Callitas Therapeutics signs LOI with Simply Wholeistic, updates on THC & CBD...

Callitas Therapeutics (CSE:LILY) (OTCQB:MPHMF) Vice President of Sales & Business Development Joshua Maurice tells Proactive Investors the pharma company has signed a letter of intent with Simply Wholeistic to manufacture  its CannaStrip products in the U.S. Maurice added that as...

on 04/25/2019

2 min read